Literature DB >> 2855792

The next frontier in the molecular biology of the opioid system. The opioid receptors.

O Civelli1, C Machida, J Bunzow, P Albert, E Hanneman, J Salon, J Bidlack, D Grandy.   

Abstract

The analgesic and euphoric properties of some plant alkaloids such as morphine have been known and exploited for centuries. In contrast, only during the last twenty years have we begun to unravel the molecular basis by which opiates exert their effects, mechanisms important to our general understanding of the nervous system. The analgesic response to opiates is the result of a cascade of biochemical events that are triggered by the interaction of the opiate with specific macromolecular components found on the membranes of nervous system tissues, the opioid receptors. The endogenous ligands of these receptors are small peptides, the opioid peptides. Although much has been learned about the structures and the mode of synthesis of the opioid peptides, little is understood about the structure of their receptors. The application of molecular genetic techniques was of great importance to the studies of the opioid peptides. It is now expected that this same technology will unravel the physical mysteries of the opioid receptors.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2855792     DOI: 10.1007/bf02935742

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  84 in total

1.  High-affinity enkephalin-degrading peptidase in brain is increased after morphine.

Authors:  B Malfroy; J P Swerts; A Guyon; B P Roques; J C Schwartz
Journal:  Nature       Date:  1978-11-30       Impact factor: 49.962

2.  Direct activation of mammalian atrial muscarinic potassium channels by GTP regulatory protein Gk.

Authors:  A Yatani; J Codina; A M Brown; L Birnbaumer
Journal:  Science       Date:  1987-01-09       Impact factor: 47.728

3.  Primary structure of porcine cardiac muscarinic acetylcholine receptor deduced from the cDNA sequence.

Authors:  T Kubo; A Maeda; K Sugimoto; I Akiba; A Mikami; H Takahashi; T Haga; K Haga; A Ichiyama; K Kangawa
Journal:  FEBS Lett       Date:  1986-12-15       Impact factor: 4.124

4.  Isolation and characterization of a new cellular oncogene encoding a protein with multiple potential transmembrane domains.

Authors:  D Young; G Waitches; C Birchmeier; O Fasano; M Wigler
Journal:  Cell       Date:  1986-06-06       Impact factor: 41.582

5.  Primary structure of alpha-subunit precursor of Torpedo californica acetylcholine receptor deduced from cDNA sequence.

Authors:  M Noda; H Takahashi; T Tanabe; M Toyosato; Y Furutani; T Hirose; M Asai; S Inayama; T Miyata; S Numa
Journal:  Nature       Date:  1982-10-28       Impact factor: 49.962

6.  Metkephamid, a systemically active analog of methionine enkephalin with potent opioid alpha-receptor activity.

Authors:  R C Frederickson; E L Smithwick; R Shuman; K G Bemis
Journal:  Science       Date:  1981-02-06       Impact factor: 47.728

7.  High-efficiency cloning of full-length cDNA.

Authors:  H Okayama; P Berg
Journal:  Mol Cell Biol       Date:  1982-02       Impact factor: 4.272

8.  Identification of a family of muscarinic acetylcholine receptor genes.

Authors:  T I Bonner; N J Buckley; A C Young; M R Brann
Journal:  Science       Date:  1987-07-31       Impact factor: 47.728

9.  Pharmacological characterization of the epsilon-opiate receptor.

Authors:  R Schulz; M Wüster; A Herz
Journal:  J Pharmacol Exp Ther       Date:  1981-03       Impact factor: 4.030

10.  Stereospecific binding of the potent narcotic analgesic (3H) Etorphine to rat-brain homogenate.

Authors:  E J Simon; J M Hiller; I Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  1973-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.